Haemonetics (HAE) Cost of Revenue (2009 - 2026)
Haemonetics (HAE) posted quarterly Cost of Revenue of $148.1 million for Q1 2026, up 7.7% year-over-year from $137.5 million in Q1 2025, and up 8.46% quarter-over-quarter from $136.6 million in Q4 2025.
Haemonetics (HAE) Cost of Revenue (2009 - 2026) Analysis & Trends
Haemonetics' Cost of Revenue history runs 18 years deep, the most recent figure standing at $148.1 million for Q1 2026.
- In Q1 2026, Cost of Revenue rose 7.7% year-over-year to $148.1 million; the TTM figure through Mar 2026 stood at $546.4 million (down 10.69% YoY), while the FY2026 annual figure was $546.4 million, down 10.69% from the prior year.
- Cost of Revenue for Q1 2026 stood at $148.1 million, up from $136.6 million in the prior quarter.
- The five-year high for Cost of Revenue was $167.4 million in Q1 2024, with the low at $119.2 million in Q3 2022.
- The 5-year median for Cost of Revenue is $145.3 million (2022), against an average of $143.3 million.
- The sharpest annual moves came in 2022 and 2025: Cost of Revenue rose 20.95% in 2022, then retreated 19.91% in 2025.
- Haemonetics' Cost of Revenue stood at $146.6 million in 2022, then climbed by 8.04% to $158.4 million in 2023, then fell by 2.14% to $155.0 million in 2024, then retreated by 11.88% to $136.6 million in 2025, then increased by 8.46% to $148.1 million in 2026.
- Business Quant data shows HAE's Cost of Revenue at $148.1 million in Q1 2026, $136.6 million in Q4 2025, and $132.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 196.58 Bn | 190.98 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 127.35 Bn | 123.88 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 118.25 Bn | 109.03 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.32 Bn | 73.78 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.26 Bn | 33.16 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 32.92 Bn | 30.82 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Smith & Nephew | 26.16 Bn | 25.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.91 Bn | 22.58 Bn | 4.55 Bn | 5.06 Bn |
| 10 | Haemonetics | 4.77 Bn | 4.55 Bn | 202.80 Mn | 136.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 136.58 Mn |
| Jun 27, 2026 | 136.58 Mn |
| Mar 28, 2026 | 148.14 Mn |
| Mar 28, 2026 | 148.14 Mn |
| Dec 27, 2025 | 136.58 Mn |
| Dec 27, 2025 | 136.58 Mn |
| Sep 27, 2025 | 132.57 Mn |
| Sep 27, 2025 | 132.57 Mn |
| Jun 28, 2025 | 129.15 Mn |
| Jun 28, 2025 | 129.15 Mn |
| Mar 29, 2025 | 137.55 Mn |
| Mar 29, 2025 | 137.55 Mn |
| Dec 28, 2024 | 155.00 Mn |
| Dec 28, 2024 | 155.00 Mn |
| Sep 28, 2024 | 158.07 Mn |
| Sep 28, 2024 | 158.07 Mn |
| Jun 29, 2024 | 161.25 Mn |
| Jun 29, 2024 | 161.25 Mn |
| Mar 30, 2024 | 167.38 Mn |
| Mar 30, 2024 | 167.38 Mn |